Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Doxorubicin and Microtubules: Mechanisms of Chemotherapy-Induced Cognitive Impairment
EF 2018-19
Résumé
The study will focus on identifying microtubule (MT) destabilization as a component factor of chemotherapy-induced cognitive dysfunction (CICI). With increasing numbers of cancer survivorship, symptoms of chemotherapy are becoming more of a concern. Deficits in memory are a common complaint of chemo patients, lasting months to years, and are correlated with reductions in quality of life and well-being. The molecular mechanisms underlying CICI have remained largely unknown. Evidence suggests oxidative damage of biomolecules as a key factor to CICI. This study focuses on the impact of doxorubicin (DOX) on MT stabilization and subsequent changes in spatial memory, and aims to demonstrate that stabilization of MT protects against DOX-induced hippocampal neuron damage, neuron death, and impairments in spatial memory. Mice will be administered DOX and will be compared on measures of MT-density, axon integrity, neuron survival, and spatial memory with mice administered both DOX and caltubin, via analysis of electron-microscopy, immunohistochemical analysis, and the Morris water maze. Caltubin is a protein that is known to stabilize MT polymers and induce axon growth and regeneration after injury in mammalian cells. It is expected that stabilization of MT with caltubin will significantly rectify loss of neuronal MT density, axon degeneration, and neuron degeneration within the hippocampus after DOX administration and consequently will improve spatial memory. This will provide sound evidence of microtubule destabilization as one of the mechanisms underlying CICI. This research could provide insight into mechanisms of other neurocognitive disorders that have an oxidative component (eg. Alzheimer's Disease), and be taken into consideration of future chemotherapy developments.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
411237
Name
Eide Sarah J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Doxorubicin and Microtubules: Mechanisms of Chemotherapy-Induced Cognitive Impairment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Caltubin; Cancer; Chemotherapy; Doxorubicin; Learning; Memory; Microtubules; Neurodegeneration; Oxidative-Stress; Quality-Of-Life
Abstract
The study will focus on identifying microtubule (MT) destabilization as a component factor of chemotherapy-induced cognitive dysfunction (CICI). With increasing numbers of cancer survivorship, symptoms of chemotherapy are becoming more of a concern. Deficits in memory are a common complaint of chemo patients, lasting months to years, and are correlated with reductions in quality of life and well-being. The molecular mechanisms underlying CICI have remained largely unknown. Evidence suggests oxidative damage of biomolecules as a key factor to CICI. This study focuses on the impact of doxorubicin (DOX) on MT stabilization and subsequent changes in spatial memory, and aims to demonstrate that stabilization of MT protects against DOX-induced hippocampal neuron damage, neuron death, and impairments in spatial memory. Mice will be administered DOX and will be compared on measures of MT-density, axon integrity, neuron survival, and spatial memory with mice administered both DOX and caltubin, via analysis of electron-microscopy, immunohistochemical analysis, and the Morris water maze. Caltubin is a protein that is known to stabilize MT polymers and induce axon growth and regeneration after injury in mammalian cells. It is expected that stabilization of MT with caltubin will significantly rectify loss of neuronal MT density, axon degeneration, and neuron degeneration within the hippocampus after DOX administration and consequently will improve spatial memory. This will provide sound evidence of microtubule destabilization as one of the mechanisms underlying CICI. This research could provide insight into mechanisms of other neurocognitive disorders that have an oxidative component (eg. Alzheimer's Disease), and be taken into consideration of future chemotherapy developments.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Eide, Sarah J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~